Literature DB >> 10837946

Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison.

G O De Meerleer1, L A Vakaet, W R De Gersem, C De Wagter, B De Naeyer, W De Neve.   

Abstract

PURPOSE: To evaluate whether intensity modulated radiotherapy (IMRT) by static segmented beams allows the dose to the main portion of the prostate target to escalate while keeping the maximal dose at the anterior rectal wall at 72 Gy. The value of such IMRT plans was analyzed by comparison with non-IMRT plans using the same beam incidences. METHODS AND MATERIALS: We performed a planning study on the CT data of 32 consecutive patients with localized adenocarcinoma of the prostate. Three fields in the transverse plane with gantry angles of 0 degrees, 116 degrees, and 244 degrees were isocentered at the center of gravity of the target volume (prostate and seminal vesicles). The geometry of the beams was determined by beam's eye view autocontouring of the target volume with a margin of 1.5 cm. In study 1, the beam weights were determined by a human planner (3D-man) or by computer optimization using a biological objective function with (3D-optim-lim) or without (3D-optim-unlim) a physical term to limit target dose inhomogeneity. In study 2, the 3 beam incidences mentioned above were used and in-field uniform segments were added to allow IMRT. Plans with (IMRT-lim) or without (IMRT-unlim) constraints on target dose inhomogeneity were compared. In the IMRT-lim plan, target dose inhomogeneity was constrained between 15% and 20%. After optimization, plans in both studies were normalized to a maximal rectal dose of 72 Gy. Biological (tumor control probability [TCP], normal tissue complication probability [NTCP]) and physical indices for tumor control and normal tissue complication probabilities were computed, as well as the probability of the uncomplicated local control (P+).
RESULTS: The IMRT-lim plan was superior to all other plans concerning TCP (p < 0.0001). The IMRT-unlim plan had the worst TCP. Within the 3D plans, the 3D-optim-unlim had the best TCP, which was significantly different from the 3D-optim-lim plan (p = 0.0003). For rectal NTCP, both IMRT plans were superior to all other plans (p < 0.0001). The IMRT-unlim plan was significantly better than the IMRT-lim plan (p < 0.0001). Again, 3D-optim-unlim was superior to the other 3D plans (p < 0. 0007). Physical endpoints for target showed the mean minimal target dose to be the lowest in the IMRT-unlim plan, caused by a large target dose inhomogeneity (TDI). Medial target dose, 90th percentile, and maximal target dose were significantly higher in both IMRT plans. Physical endpoints for the rectum showed the IMRT-unlim plan to be superior compared to all other plans. There was a strong correlation between the 65th percentile (Rp65) and rectal NTCP (correlation coefficient > or =89%). For bladder, maximal bladder dose was significantly higher in the IMRT-unlim plan compared to all other plans (p < or = 0.0001).P+ was significantly higher in both IMRT-plans than in all other plans. The 3D-optim-unlim plan was significantly better than the two other 3D plans (p < 0.0001).
CONCLUSION: IMRT significantly increases the ratio of TCP over NTCP of the rectum in the treatment of prostate cancer. However, constraints for TDI are needed, because a high degree of TDI reduced minimal target dose. IMRT improved uncomplicated local control probability. In our department, IMRT by static segmented beams is planned and delivered in a cost-effective way. IMRT-lim has replaced non-modulated conformal radiotherapy as the standard treatment for prostate cancer.

Entities:  

Mesh:

Year:  2000        PMID: 10837946     DOI: 10.1016/s0360-3016(00)00419-3

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  31 in total

Review 1.  Radiation medicine innovations for the new millenium.

Authors:  Dwight E Heron; Karen D Godette; Ray A Wynn; V Elayne Arterbery; Oscar A Streeter; Mack Roach; Joseph R Simpson; Melissa Blough; Charles R Thomas
Journal:  J Natl Med Assoc       Date:  2003-01       Impact factor: 1.798

Review 2.  Volumetric modulated arc therapy: a review of current literature and clinical use in practice.

Authors:  M Teoh; C H Clark; K Wood; S Whitaker; A Nisbet
Journal:  Br J Radiol       Date:  2011-11       Impact factor: 3.039

Review 3.  Technological advances in radiation therapy for prostate cancer.

Authors:  Mehee Choi; Arthur Y Hung
Journal:  Curr Urol Rep       Date:  2010-05       Impact factor: 3.092

4.  Clinical implementation of volumetric intensity-modulated arc therapy (VMAT) with ERGO++.

Authors:  Dirk Wolff; Florian Stieler; Brigitte Hermann; Katharina Heim; Sven Clausen; Jens Fleckenstein; Martin Polednik; Volker Steil; Frederik Wenz; Frank Lohr
Journal:  Strahlenther Onkol       Date:  2010-04-26       Impact factor: 3.621

5.  Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison.

Authors:  Alexei Trofimov; Paul L Nguyen; John J Coen; Karen P Doppke; Robert J Schneider; Judith A Adams; Thomas R Bortfeld; Anthony L Zietman; Thomas F Delaney; William U Shipley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-05-21       Impact factor: 7.038

6.  Implementation of a dose gradient method into optimization of dose distribution in prostate cancer 3D-CRT plans.

Authors:  Marta K Giżyńska; Paweł F Kukołowicz; Paweł Kordowski
Journal:  Rep Pract Oncol Radiother       Date:  2014-05-03

7.  A comparison of clinical outcomes between three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer.

Authors:  Takuya Shimizuguchi; Keiji Nihei; Tomoyuki Okano; Yumiko Machitori; Kei Ito; Katsuyuki Karasawa
Journal:  Int J Clin Oncol       Date:  2016-10-24       Impact factor: 3.402

Review 8.  Late toxicity rates following definitive radiotherapy for prostate cancer.

Authors:  Nitin Ohri; Adam P Dicker; Timothy N Showalter
Journal:  Can J Urol       Date:  2012-08       Impact factor: 1.344

9.  Rapid loss of bone mass and strength in mice after abdominal irradiation.

Authors:  Dan Jia; Dana Gaddy; Larry J Suva; Peter M Corry
Journal:  Radiat Res       Date:  2011-08-22       Impact factor: 2.841

10.  Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer.

Authors:  B A Jereczek-Fossa; A Maucieri; G Marvaso; S Gandini; C Fodor; D Zerini; G Riva; O Alessandro; A Surgo; S Volpe; G Fanetti; S Arculeo; M A Zerella; S Parisi; P Maisonneuve; A Vavassori; F Cattani; R Cambria; C Garibaldi; A Starzyńska; G Musi; O De Cobelli; M Ferro; F Nolè; D Ciardo; R Orecchia
Journal:  Med Oncol       Date:  2018-11-27       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.